SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001804591-24-000032
Filing Date
2024-05-23
Accepted
2024-05-23 16:07:02
Documents
14
Period of Report
2024-05-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K me-20240523.htm   iXBRL 8-K 25938
2 EX-99.1 me-20240523x8kxexx991.htm EX-99.1 227765
  Complete submission text file 0001804591-24-000032.txt   396762

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20240523.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20240523_lab.xml EX-101.LAB 21633
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20240523_pre.xml EX-101.PRE 12508
17 EXTRACTED XBRL INSTANCE DOCUMENT me-20240523_htm.xml XML 2734
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 24978207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)